Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01373489 · ClinicalTrials.gov registry record · NA

Technology-assisted Case Management in Adults With Type 2 Diabetes

A NA study of Diabetes, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
113
Enrollment target
1
Study location

NCT01373489: Completed NA study of Diabetes, sponsored by State University of New York at Buffalo.

NCT01373489 is a NA study of Diabetes that has completed, run by State University of New York at Buffalo. The registered enrollment target is 113 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01373489, a NA study of Diabetes, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to help low income patients achieve and maintain better self-management skills and improve blood sugar levels, using a 2-in-1 blood glucose and blood pressure monitoring system and nurse case management. Patients must be served at a Federally Qualified Health Center (FQHC) in coastal South Carolina.

Primary Outcome

Hemoglobin A1c (HbA1c) was measured at 6 months post randomization

Conditions Studied

Interventions

  • BEHAVIORAL Technology-Assisted Case Management

Study Locations (1)

South Carolina

  • Franklin C. Fetter Family Health Center, Inc. - Charleston

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2011-07
Est. Completion 2016-06
Phase NA

What the finished NCT01373489 record still lists

NCT01373489 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Technology-Assisted Case Management is the first listed.

NCT01373489 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT01373489 about?

NCT01373489 is a clinical study titled "Technology-assisted Case Management in Adults With Type 2 Diabetes". The purpose of this study is to help low income patients achieve and maintain better self-management skills and improve blood sugar levels, using a 2-in-1 blood glucose and blood pressure monitoring system and nurse case management. Patients must be served at a Federally Qualified Health Center (FQH...

What is the current status of trial NCT01373489?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2011-07. Estimated completion is 2016-06.

What conditions does trial NCT01373489 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01373489?

The interventions under investigation include: Technology-Assisted Case Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT01373489?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01373489 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01373489's enrollment target sits among peer trials

113 186th of 338 higher than 153 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00748254 · 113 participants

    Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

  • NCT04753190 · 113 participants · NA

    Light Timing Study

  • NCT05799248 · 113 participants · Phase 3

    Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

  • NCT07216105 · 113 participants · Phase 1

    FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01373489, the US trial registry maintained by the National Library of Medicine. NCT01373489 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.